Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Ram Vaidhyanath

Neuroradiology

View

Dr. Judith Gadde

Neuroradiology · Lurie Children's Hospital

View

Dr. Wende Gibbs

Neuroradiology · Barrow Neurological Institute

View

Dr. Daniel Gewolb

Neuroradiology · University of Miami

View

Dr. Sumir Patel

Neuroradiology · Emory University

View

Dr. Julie Bulman

Interventional Radiology · BIDMC

View

Dr. Monica Sheth

Breast Imaging · NYU Langone

View

Dr. Victoria Chernyak

Abdominal Imaging · CUIMC

View

Dr. Laura Hayes

Peds Radiology · Children's Healthcare of Atlanta

View

Dr. Amy Patel

Breast Imaging · UKHS

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Pretreatment Perfusion-Collateral Impairment Identifies Outcome Heterogeneity After Thrombectomy Reperfusion.

    Aug 3, 2026DOI: 10.3174/ajnr.a9568Journal ArticleAJNR

    Written by: Derek A TsangMona GadKarthik LalwaniHamza A SalimDhairya A LakhaniAakanksha SriwastwaVivek S Yedavalli

    Find these authors on Roon

    MG
    Dr. Mona Gad
    Neuroradiology

    Summary

    PURPOSE: Outcomes remain heterogeneous after angiographically successful endovascular thrombectomy (EVT), and pretreatment perfusion-collateral status may contribute to this variability. We evaluated whether the Perfusion Collateral Impairment Score (PCIS), a composite of hypoperfusion intensity ratio, cerebral blood volume index, and prolonged venous transit, was associated with 90-day functional outcome across mTICI reperfusion groups after EVT.METHODS: This retrospective secondary analysis included patients from 2 hospitals with ICA, M1, or M2 occlusion who underwent EVT and had available pretreatment CT perfusion, PCIS, final mTICI grade, and valid 90-day modified Rankin Scale (mRS). PCIS was dichotomized as low burden (0-1) versus high burden (2-3), and successful reperfusion was defined as mTICI 2b-3. The primary outcome was 90-day mRS 0-2. Multivariable logistic regression among patients with mTICI 2b-3 adjusted for age, continuous admission NIHSS, ASPECTS, intravenous thrombolysis, admission glucose, occlusion site, and mTICI 2b versus 2c-3. Prespecified NIHSS-threshold, ordinal PCIS, component, and model-performance analyses were also performed.RESULTS: Among 194 patients, 172 achieved mTICI 2b-3 reperfusion. Favorable outcome occurred in 63/108 patients (58.3%) with PCIS 0-1 versus 27/64 (42.2%) with PCIS 2-3. In the primary model using continuous NIHSS, high PCIS burden was associated with lower odds of favorable outcome, although the confidence interval crossed unity (adjusted OR, 0.56; 95% CI, 0.25-1.25; p=.16). In the prespecified NIHSS >5 model, high PCIS burden remained independently associated with lower odds of favorable outcome (adjusted OR, 0.44; 95% CI, 0.20-0.94; p=.04). Each 1-point increase in ordinal PCIS was associated with lower odds of favorable outcome (adjusted OR, 0.67; 95% CI, 0.45-0.99; p=.05), with improved model fit (likelihood-ratio p=.04). PVT was the only independently associated component (adjusted OR, 0.44; 95% CI, 0.20-0.95; p=.04).CONCLUSIONS: Pretreatment PCIS identified clinically meaningful outcome heterogeneity after EVT. High PCIS burden remained independently associated with unfavorable outcome in the prespecified NIHSS >5 model, while ordinal PCIS demonstrated a graded relationship with outcome and improved model fit. These findings support PCIS as a complementary pretreatment risk-stratification marker after successful reperfusion.
    MGDr. Mona Gad

    Dr. Mona Gad

    Radiology · Neuroradiology
    monag